# National Healthcare Corp: financial statements, quarterly

NHC · NYSE · CIK 1047335 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/nhc.md) · [Financials](/companies/nhc/financials.md) · [Filings](/companies/nhc/filings.md) · [Insiders](/companies/nhc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nhc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [288](/filings/0001437749-24-033970.md) | [301 d](/filings/0001437749-26-005910.md) | [297](/filings/0001437749-25-015499.md) | [301](/filings/0001437749-25-025500.md) | [340](/filings/0001437749-25-033631.md) | [369 d](/filings/0001437749-26-005910.md) | [374](/filings/0001437749-26-015612.md) | [375](/filings/0001437749-26-026199.md) | [383](/filings/0001437749-25-033631.md) | [387 d](/filings/0001437749-26-005910.md) | [382](/filings/0001437749-26-015612.md) | [408](/filings/0001437749-26-026199.md) |
| Operating income | $m | [13.0](/filings/0001437749-24-033970.md) | [20.4 d](/filings/0001437749-26-005910.md) | [15.7](/filings/0001437749-25-015499.md) | [22.5](/filings/0001437749-25-025500.md) | [22.8](/filings/0001437749-25-033631.md) | [28.9 d](/filings/0001437749-26-005910.md) | [30.8](/filings/0001437749-26-015612.md) | [34.1](/filings/0001437749-26-026199.md) | [30.4](/filings/0001437749-25-033631.md) | [33.1 d](/filings/0001437749-26-005910.md) | [32.3](/filings/0001437749-26-015612.md) | [48.9](/filings/0001437749-26-026199.md) |
| Interest expense | $m | [0.1](/filings/0001437749-24-033970.md) | [0.1 d](/filings/0001437749-25-005928.md) | [0.0](/filings/0001437749-24-015736.md) | [0.0](/filings/0001437749-24-025603.md) | [1.7](/filings/0001437749-24-033970.md) | [2.3 d](/filings/0001437749-25-005928.md) | [2.1](/filings/0001437749-26-015612.md) | [2.0](/filings/0001437749-26-026199.md) | [1.5](/filings/0001437749-25-033631.md) | [0.8 d](/filings/0001437749-26-005910.md) | [0.3](/filings/0001437749-26-015612.md) | [0.0](/filings/0001437749-26-026199.md) |
| Income tax | $m | [3.9](/filings/0001437749-24-033970.md) | [8.7 d](/filings/0001437749-26-005910.md) | [9.5](/filings/0001437749-25-015499.md) | [9.5](/filings/0001437749-25-025500.md) | [15.3](/filings/0001437749-25-033631.md) | [0.0 d](/filings/0001437749-26-005910.md) | [11.4](/filings/0001437749-26-015612.md) | [8.1](/filings/0001437749-26-026199.md) | [13.4](/filings/0001437749-25-033631.md) | [6.9 d](/filings/0001437749-26-005910.md) | [8.7](/filings/0001437749-26-015612.md) | [13.5](/filings/0001437749-26-026199.md) |
| Net income | $m | [10.4](/filings/0001437749-24-033970.md) | [28.4 d](/filings/0001437749-26-005910.md) | [26.2](/filings/0001437749-25-015499.md) | [26.8](/filings/0001437749-25-025500.md) | [42.8](/filings/0001437749-25-033631.md) | [6.1 d](/filings/0001437749-26-005910.md) | [32.2](/filings/0001437749-26-015612.md) | [23.7](/filings/0001437749-26-026199.md) | [39.2](/filings/0001437749-25-033631.md) | [24.8 d](/filings/0001437749-26-005910.md) | [35.9](/filings/0001437749-26-015612.md) | [40.3](/filings/0001437749-26-026199.md) |
| Diluted EPS | $ per share | [0.68](/filings/0001437749-24-033970.md) | not reported | [1.69](/filings/0001437749-25-015499.md) | [1.73](/filings/0001437749-25-025500.md) | [2.73](/filings/0001437749-25-033631.md) | not reported | [2.07](/filings/0001437749-26-015612.md) | [1.52](/filings/0001437749-26-026199.md) | [2.50](/filings/0001437749-25-033631.md) | not reported | [2.27](/filings/0001437749-26-015612.md) | [2.54](/filings/0001437749-26-026199.md) |
| Basic EPS | $ per share | [0.68](/filings/0001437749-24-033970.md) | not reported | [1.71](/filings/0001437749-25-015499.md) | [1.74](/filings/0001437749-25-025500.md) | [2.78](/filings/0001437749-25-033631.md) | not reported | [2.09](/filings/0001437749-26-015612.md) | [1.53](/filings/0001437749-26-026199.md) | [2.53](/filings/0001437749-25-033631.md) | not reported | [2.31](/filings/0001437749-26-015612.md) | [2.58](/filings/0001437749-26-026199.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [100](/filings/0001437749-24-033970.md) | [107](/filings/0001437749-26-005910.md) | [94.0](/filings/0001437749-25-015499.md) | [136](/filings/0001437749-25-025500.md) | [84.8](/filings/0001437749-25-033631.md) | [76.1](/filings/0001437749-26-005910.md) | [90.4](/filings/0001437749-26-015612.md) | [111](/filings/0001437749-26-026199.md) | [131](/filings/0001437749-25-033631.md) | [92.8](/filings/0001437749-26-026199.md) | [85.5](/filings/0001437749-26-015612.md) | [39.2](/filings/0001437749-26-026199.md) |
| Current assets | $m | [383](/filings/0001437749-23-030016.md) | [406](/filings/0001437749-25-005928.md) | [418](/filings/0001437749-24-015736.md) | [448](/filings/0001437749-24-025603.md) | [446](/filings/0001437749-24-033970.md) | [424](/filings/0001437749-26-005910.md) | [455](/filings/0001437749-25-015499.md) | [463](/filings/0001437749-25-025500.md) | [494](/filings/0001437749-25-033631.md) | [462](/filings/0001437749-26-026199.md) | [466](/filings/0001437749-26-015612.md) | [440](/filings/0001437749-26-026199.md) |
| Total assets | $m | [1,282](/filings/0001437749-23-030016.md) | [1,311](/filings/0001437749-25-005928.md) | [1,320](/filings/0001437749-24-015736.md) | [1,340](/filings/0001437749-24-025603.md) | [1,563](/filings/0001437749-24-033970.md) | [1,524](/filings/0001437749-26-005910.md) | [1,549](/filings/0001437749-25-015499.md) | [1,562](/filings/0001437749-25-025500.md) | [1,572](/filings/0001437749-25-033631.md) | [1,526](/filings/0001437749-26-026199.md) | [1,524](/filings/0001437749-26-015612.md) | [1,537](/filings/0001437749-26-026199.md) |
| Current liabilities | $m | [205](/filings/0001437749-23-030016.md) | [214](/filings/0001437749-25-005928.md) | [206](/filings/0001437749-24-015736.md) | [217](/filings/0001437749-24-025603.md) | [248](/filings/0001437749-24-033970.md) | [235](/filings/0001437749-26-005910.md) | [239](/filings/0001437749-25-015499.md) | [269](/filings/0001437749-25-025500.md) | [282](/filings/0001437749-25-033631.md) | [254](/filings/0001437749-26-026199.md) | [251](/filings/0001437749-26-015612.md) | [236](/filings/0001437749-26-026199.md) |
| Total liabilities | $m | [395](/filings/0001437749-23-030016.md) | [400](/filings/0001437749-25-005928.md) | [393](/filings/0001437749-24-015736.md) | [392](/filings/0001437749-24-025603.md) | [576](/filings/0001437749-24-033970.md) | [541](/filings/0001437749-26-005910.md) | [541](/filings/0001437749-25-015499.md) | [537](/filings/0001437749-25-025500.md) | [514](/filings/0001437749-25-033631.md) | [452](/filings/0001437749-26-026199.md) | [427](/filings/0001437749-26-015612.md) | [409](/filings/0001437749-26-026199.md) |
| Long-term debt | $m | not reported | [0.0](/filings/0001437749-25-005928.md) | not reported | not reported | [130](/filings/0001437749-25-005928.md) | [130](/filings/0001437749-26-005910.md) | [127](/filings/0001437749-25-015499.md) | [103](/filings/0001437749-25-025500.md) | [65.6](/filings/0001437749-25-033631.md) | [32.5](/filings/0001437749-26-026199.md) | [0.0](/filings/0001437749-26-015612.md) | [0.0](/filings/0001437749-26-026199.md) |
| Current portion of debt | $m | not reported | [0.0](/filings/0001437749-25-005928.md) | not reported | not reported | [7.5](/filings/0001437749-25-005928.md) | [7.5](/filings/0001437749-26-005910.md) | [7.5](/filings/0001437749-25-015499.md) | [7.5](/filings/0001437749-25-025500.md) | [7.5](/filings/0001437749-25-033631.md) | [7.5](/filings/0001437749-26-026199.md) | [0.0](/filings/0001437749-26-015612.md) | [0.0](/filings/0001437749-26-026199.md) |
| Shareholders' equity | $m | [885](/filings/0001437749-23-030016.md) | [909](/filings/0001437749-25-005928.md) | [925](/filings/0001437749-24-015736.md) | [946](/filings/0001437749-24-025603.md) | [983](/filings/0001437749-24-033970.md) | [980](/filings/0001437749-26-005910.md) | [1,005](/filings/0001437749-25-015499.md) | [1,022](/filings/0001437749-25-025500.md) | [1,053](/filings/0001437749-25-033631.md) | [1,069](/filings/0001437749-26-026199.md) | [1,091](/filings/0001437749-26-015612.md) | [1,122](/filings/0001437749-26-026199.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [32.3 d](/filings/0001437749-24-033970.md) | [25.7 d](/filings/0001437749-26-005910.md) | [9.6](/filings/0001437749-25-015499.md) | [50.7 d](/filings/0001437749-25-025500.md) | [34.2 d](/filings/0001437749-25-033631.md) | [12.8 d](/filings/0001437749-26-005910.md) | [39.3](/filings/0001437749-26-015612.md) | [62.8 d](/filings/0001437749-26-026199.md) | [66.2 d](/filings/0001437749-25-033631.md) | [16.8 d](/filings/0001437749-26-005910.md) | [62.5](/filings/0001437749-26-015612.md) | [43.3 d](/filings/0001437749-26-026199.md) |
| Capital expenditure | $m | [6.5 d](/filings/0001437749-24-033970.md) | [8.6 d](/filings/0001437749-26-005910.md) | [6.0](/filings/0001437749-25-015499.md) | [7.8 d](/filings/0001437749-25-025500.md) | [5.7 d](/filings/0001437749-25-033631.md) | [8.2 d](/filings/0001437749-26-005910.md) | [6.1](/filings/0001437749-26-015612.md) | [10.2 d](/filings/0001437749-26-026199.md) | [9.7 d](/filings/0001437749-25-033631.md) | [10.4 d](/filings/0001437749-26-005910.md) | [9.6](/filings/0001437749-26-015612.md) | [12.5 d](/filings/0001437749-26-026199.md) |
| Dividends paid | $m | [9.0 d](/filings/0001437749-24-033970.md) | [9.0 d](/filings/0001437749-26-005910.md) | [9.1](/filings/0001437749-25-015499.md) | [9.1 d](/filings/0001437749-25-025500.md) | [9.4 d](/filings/0001437749-25-033631.md) | [9.4 d](/filings/0001437749-26-005910.md) | [9.4](/filings/0001437749-26-015612.md) | [9.4 d](/filings/0001437749-26-026199.md) | [9.9 d](/filings/0001437749-25-033631.md) | [9.9 d](/filings/0001437749-26-005910.md) | [9.9](/filings/0001437749-26-015612.md) | [10.0 d](/filings/0001437749-26-026199.md) |
| Share repurchases | $m | [0.0 d](/filings/0001437749-24-033970.md) | [0.0 d](/filings/0001437749-26-005910.md) | [9.9](/filings/0001437749-25-015499.md) | [1.5 d](/filings/0001437749-25-025500.md) | [2.1 d](/filings/0001437749-25-033631.md) | [0.0 d](/filings/0001437749-26-005910.md) | [1.7](/filings/0001437749-26-015612.md) | [4.7 d](/filings/0001437749-26-026199.md) | [3.2 d](/filings/0001437749-25-033631.md) | [5.2 d](/filings/0001437749-26-005910.md) | [16.3](/filings/0001437749-26-015612.md) | [7.2 d](/filings/0001437749-26-026199.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [15.4](/filings/0001437749-23-030016.md) | [15.4](/filings/0001437749-24-015736.md) | [15.3](/filings/0001437749-24-025603.md) | [15.3](/filings/0001437749-24-033970.md) | [15.5](/filings/0001437749-25-015499.md) | [15.6](/filings/0001437749-25-025500.md) | [15.7](/filings/0001437749-25-033631.md) | [15.6](/filings/0001437749-26-015612.md) | [15.6](/filings/0001437749-26-026199.md) | [15.7](/filings/0001437749-25-033631.md) | [15.8](/filings/0001437749-26-015612.md) | [15.9](/filings/0001437749-26-026199.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 15,661,395 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001437749-26-026199.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.